Members of the DAN family are BMP antagonists that form highly stable noncovalent dimers

Journal of Molecular Biology

Volumn 424, Issue 5, 2012, Pages 313-327

  Kattamuri, Chandramohan ^a   Luedeke, David M ^a   Nolan, Kristof ^a   Rankin, Scott A ^a   Greis, Kenneth D ^a   Zorn, Aaron M ^a   Thompson, Thomas B ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

BMP antagonist; bone morphogenetic protein (BMP); DAN family; protein related to DAN and cerberus (PRDC); transforming growth factor (TGF )

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; CYSTEINE; DIMER; LIGAND; OLIGOMER; PROTEIN DIFFERENTIAL SCREENING SELECTED GENE ABBERATIVE IN NEUROBLASTOMA; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; SCLEROSTIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; COVALENT BOND; DIFFERENTIAL SCREENING SELECTED GENE ABBERATIVE IN NEUROBLASTOMA; GENE; GENE MUTATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DENATURATION;

EID: 84869227523     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2012.10.003     Document Type: Article

References (69)

1. B.L. Hogan Bone morphogenetic proteins in development Curr. Opin. Genet. Dev. 6 1996 432 438
2. J. Massague How cells read TGF-β signals Nat. Rev., Mol. Cell Biol. 1 2000 169 178
3. J. Groppe, J. Greenwald, E. Wiater, J. Rodriguez-Leon, A.N. Economides, and W. Kwiatkowski Structural basis of BMP signalling inhibition by the cystine knot protein Noggin Nature 420 2002 636 642
4. D.R. Hsu, A.N. Economides, X. Wang, P.M. Eimon, and R.M. Harland The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities Mol. Cell 1 1998 673 683
5. T.B. Thompson, T.F. Lerch, R.W. Cook, T.K. Woodruff, and T.S. Jardetzky The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding Dev. Cell 9 2005 535 543
6. R. Stamler, H.T. Keutmann, Y. Sidis, C. Kattamuri, A. Schneyer, and T.B. Thompson The structure of FSTL3.activin A complex. Differential binding of N-terminal domains influences follistatin-type antagonist specificity J. Biol. Chem. 283 2008 32831 32838
7. J.J. Pearce, G. Penny, and J. Rossant A mouse cerberus/Dan-related gene family Dev. Biol. 209 1999 98 110
8. J. Xie, and S. Fisher Twisted gastrulation enhances BMP signaling through chordin dependent and independent mechanisms Development 132 2005 383 391
9. I.I. Muller, E.W. Knapik, and A.K. Hatzopoulos Expression of the protein related to Dan and Cerberus gene - prdc - during eye, pharyngeal arch, somite, and swim bladder development in zebrafish Dev. Dyn. 235 2006 2881 2888
10. E. Stanley, C. Biben, S. Kotecha, L. Fabri, S. Tajbakhsh, and C.C. Wang DAN is a secreted glycoprotein related to Xenopus cerberus Mech. Dev. 77 1998 173 184
11. A. Glinka, W. Wu, D. Onichtchouk, C. Blumenstock, and C. Niehrs Head induction by simultaneous repression of Bmp and Wnt signalling in Xenopus Nature 389 1997 517 519
12. T. Bouwmeester, S. Kim, Y. Sasai, B. Lu, and E.M. De Robertis Cerberus is a head-inducing secreted factor expressed in the anterior endoderm of Spemann's organizer Nature 382 1996 595 601
13. L. Chi, U. Saarela, A. Railo, R. Prunskaite-Hyyrylainen, I. Skovorodkin, and S. Anthony A secreted BMP antagonist, Cer1, fine tunes the spatial organization of the ureteric bud tree during mouse kidney development PLoS One 6 2011 e27676
14. K. Koli, M. Myllarniemi, K. Vuorinen, K. Salmenkivi, M.J. Ryynanen, V.L. Kinnula, and J. Keski-Oja Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pulmonary fibrosis Am. J. Pathol. 169 2006 61 71
15. R. McMahon, M. Murphy, M. Clarkson, M. Taal, H.S. Mackenzie, and C. Godson IHG-2, a mesangial cell gene induced by high glucose, is human gremlin. Regulation by extracellular glucose concentration, cyclic mechanical strain, and transforming growth factor-β1 J. Biol. Chem. 275 2000 9901 9904
16. V. Dolan, M. Murphy, D. Sadlier, D. Lappin, P. Doran, and C. Godson Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy Am. J. Kidney Dis. 45 2005 1034 1039
17. D.W. Walsh, S.A. Roxburgh, P. McGettigan, C.C. Berthier, D.G. Higgins, and M. Kretzler Co-regulation of Gremlin and Notch signalling in diabetic nephropathy Biochim. Biophys. Acta 1782 2008 10 21
18. H. Namkoong, S.M. Shin, H.K. Kim, S.A. Ha, G.W. Cho, and S.Y. Hur The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein BMC Cancer 6 2006 74
19. J.B. Sneddon, H.H. Zhen, K. Montgomery, M. van de Rijn, A.D. Tward, and R. West Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation Proc. Natl Acad. Sci. USA 103 2006 14842 14847
20. E.M. Langenfeld, J. Bojnowski, J. Perone, and J. Langenfeld Expression of bone morphogenetic proteins in human lung carcinomas Ann. Thorac. Surg. 80 2005 1028 1032
21. T. Rothhammer, I. Poser, F. Soncin, F. Bataille, M. Moser, and A.K. Bosserhoff Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration Cancer Res. 65 2005 448 456
22. M.S. Virk, F.A. Petrigliano, N.Q. Liu, A.F. Chatziioannou, D. Stout, and C.O. Kang Influence of simultaneous targeting of the bone morphogenetic protein pathway and RANK/RANKL axis in osteolytic prostate cancer lesion in bone Bone 44 2009 160 167
23. O. Avsian-Kretchmer, and A.J. Hsueh Comparative genomic analysis of the eight-membered ring cystine knot-containing bone morphogenetic protein antagonists Mol. Endocrinol. 18 2004 1 12
24. K.B. Lintern, S. Guidato, A. Rowe, J.W. Saldanha, and N. Itasaki Characterization of wise protein and its molecular mechanism to interact with both Wnt and BMP signals J. Biol. Chem. 284 2009 23159 23168
25. S. Sudo, O. Avsian-Kretchmer, L.S. Wang, and A.J. Hsueh Protein related to DAN and cerberus is a bone morphogenetic protein antagonist that participates in ovarian paracrine regulation J. Biol. Chem. 279 2004 23134 23141
26. S. Piccolo, E. Agius, L. Leyns, S. Bhattacharyya, H. Grunz, T. Bouwmeester, and E.M. De Robertis The head inducer Cerberus is a multifunctional antagonist of Nodal, BMP and Wnt signals Nature 397 1999 707 710
27. M.S. Dionne, W.C. Skarnes, and R.M. Harland Mutation and analysis of Dan, the founding member of the Dan family of transforming growth factor β antagonists Mol. Cell. Biol. 21 2001 636 643
28. J. Sun, F.F. Zhuang, J.E. Mullersman, H. Chen, E.J. Robertson, and D. Warburton BMP4 activation and secretion are negatively regulated by an intracellular gremlin-BMP4 interaction J. Biol. Chem. 281 2006 29349 29356
29. S.E. Weidauer, P. Schmieder, M. Beerbaum, W. Schmitz, H. Oschkinat, and T.D. Mueller NMR structure of the Wnt modulator protein Sclerostin Biochem. Biophys. Res. Commun. 380 2009 160 165
30. V. Veverka, A.J. Henry, P.M. Slocombe, A. Ventom, B. Mulloy, and F.W. Muskett Characterization of the structural features and interactions of sclerostin: molecular insight into a key regulator of Wnt-mediated bone formation J. Biol. Chem. 284 2009 10890 10900
31. S. Daopin, K.A. Piez, Y. Ogawa, and D.R. Davies Crystal structure of transforming growth factor-beta 2: an unusual fold for the superfamily Science 257 1992 369 373
32. S. Radaev, Z. Zou, T. Huang, E.M. Lafer, A.P. Hinck, and P.D. Sun Ternary complex of transforming growth factor-β1 reveals isoform-specific ligand recognition and receptor recruitment in the superfamily J. Biol. Chem. 285 2010 14806 14814
33. N.Q. McDonald, R. Lapatto, J. Murray-Rust, J. Gunning, A. Wlodawer, and T.L. Blundell New protein fold revealed by a 2.3-Å resolution crystal structure of nerve growth factor Nature 354 1991 411 414
34. C. Oefner, A. D'Arcy, F.K. Winkler, B. Eggimann, and M. Hosang Crystal structure of human platelet-derived growth factor BB EMBO J. 11 1992 3921 3926
35. M.P. Schlunegger, and M.G. Grutter An unusual feature revealed by the crystal structure at 2.2 A resolution of human transforming growth factor-beta 2 Nature 358 1992 430 434
36. P. Husken-Hindi, K. Tsuchida, M. Park, A.Z. Corrigan, J.M. Vaughan, W.W. Vale, and W.H. Fischer Monomeric activin A retains high receptor binding affinity but exhibits low biological activity J. Biol. Chem. 269 1994 19380 19384
37. A.M. Brunner, M.N. Lioubin, H. Marquardt, A.R. Malacko, W.C. Wang, and R.A. Shapiro Site-directed mutagenesis of glycosylation sites in the transforming growth factor-beta 1 (TGF beta 1) and TGF beta 2 (414) precursors and of cysteine residues within mature TGF beta 1: effects on secretion and bioactivity Mol. Endocrinol. 6 1992 1691 1700
38. W.X. Liao, R.K. Moore, and S. Shimasaki Functional and molecular characterization of naturally occurring mutations in the oocyte-secreted factors bone morphogenetic protein-15 and growth and differentiation factor-9 J. Biol. Chem. 279 2004 17391 17396
39. M.M. Pulkki, D.G. Mottershead, A.H. Pasternack, P. Muggalla, H. Ludlow, and M. van Dinther A covalently dimerized recombinant human bone morphogenetic protein-15 variant identifies bone morphogenetic protein receptor type 1B as a key cell surface receptor on ovarian granulosa cells Endocrinology 153 2012 1509 1518
40. W.T. Hung, F.J. Wu, C.J. Wang, and C.W. Luo DAN (NBL1) specifically antagonizes BMP2 and BMP4 and modulates the actions of GDF9, BMP2, and BMP4 in the rat ovary Biol. Reprod. 86 2012 158
41. C. Kattamuri, D.M. Luedeke, and T.B. Thompson Expression and purification of recombinant protein related to DAN and cerberus (PRDC) Protein Expression Purif. 82 2012 389 395
42. J.N. Cash, E.B. Angerman, C. Kattamuri, K. Nolan, H. Zhao, and Y. Sidis The structure of myostatin·follistatin-like 3: N-terminal domains of follistatin-type molecules exhibit alternate modes of binding J. Biol. Chem. 287 2012 1043 1053
43. K. Kondas, G. Szlama, M. Trexler, and L. Patthy Both WFIKKN1 and WFIKKN2 have high affinity for growth and differentiation factors 8 and 11 J. Biol. Chem. 283 2008 23677 23684
44. B. Herrera, and G.J. Inman A rapid and sensitive bioassay for the simultaneous measurement of multiple bone morphogenetic proteins. Identification and quantification of BMP4, BMP6 and BMP9 in bovine and human serum BMC Cell Biol. 10 2009 20
45. K. Marom, A. Fainsod, and H. Steinbeisser Patterning of the mesoderm involves several threshold responses to BMP-4 and Xwnt-8 Mech. Dev. 87 1999 33 44
46. S. Iyer, and K.R. Acharya Tying the knot: the cystine signature and molecular-recognition processes of the vascular endothelial growth factor family of angiogenic cytokines FEBS J. 278 2011 4304 4322
47. M. Shi, J. Zhu, R. Wang, X. Chen, L. Mi, T. Walz, and T.A. Springer Latent TGF-β structure and activation Nature 474 2011 343 349
48. A.E. Harrington, S.A. Morris-Triggs, B.T. Ruotolo, C.V. Robinson, S. Ohnuma, and M. Hyvonen Structural basis for the inhibition of activin signalling by follistatin EMBO J. 25 2006 1035 1045
49. J. Greenwald, M.E. Vega, G.P. Allendorph, W.H. Fischer, W. Vale, and S. Choe A flexible activin explains the membrane-dependent cooperative assembly of TGF-β family receptors Mol. Cell 15 2004 485 489
50. β3 complex Nat. Struct. Biol. 9 2002 203 208
51. T.B. Thompson, T.K. Woodruff, and T.S. Jardetzky Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-β ligand:receptor interactions EMBO J. 22 2003 1555 1566
52. J.G. Pierce, and T.F. Parsons Glycoprotein hormones: structure and function Annu. Rev. Biochem. 50 1981 465 495
53. A.J. Lapthorn, D.C. Harris, A. Littlejohn, J.W. Lustbader, R.E. Canfield, and K.J. Machin Crystal structure of human chorionic gonadotropin Nature 369 1994 455 461
54. J.N. Cash, C.A. Rejon, A.C. McPherron, D.J. Bernard, and T.B. Thompson The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding EMBO J. 28 2009 2662 2676
55. A. Alt, L. Miguel-Romero, J. Donderis, M. Aristorena, F.J. Blanco, and A. Round Structural and functional insights into endoglin ligand recognition and binding PLoS One 7 2012 e29948
56. S. Komesli, D. Vivien, and P. Dutartre Chimeric extracellular domain type II transforming growth factor (TGF)-beta receptor fused to the Fc region of human immunoglobulin as a TGF-beta antagonist Eur. J. Biochem. 254 1998 505 513
57. D. Coudreuse, and H.C. Korswagen The making of Wnt: new insights into Wnt maturation, sorting and secretion Development 134 2007 3 12
58. C.Y. Janda, D. Waghray, A.M. Levin, C. Thomas, and K.C. Garcia Structural basis of Wnt recognition by Frizzled Science 337 2012 59 64
59. Y. Chen, T. Ali, V. Todorovic, J,.M. O'Leary, A. Kristina Downing, and D.B. Rifkin Amino acid requirements for formation of the TGF-beta-latent TGF-beta binding protein complexes J. Mol. Biol. 345 2005 175 186
60. B. Yan, and J.W. Smith A redox site involved in integrin activation J. Biol. Chem. 275 2000 39964 39972
61. C. Jacob, E. Battaglia, T. Burkholz, D. Peng, D. Bagrel, and M. Montenarh Control of oxidative posttranslational cysteine modifications: from intricate chemistry to widespread biological and medical applications Chem. Res. Toxicol. 25 2012 588 604
62. I. Dalle-Donne, R. Rossi, G. Colombo, D. Giustarini, and A. Milzani Protein S-glutathionylation: a regulatory device from bacteria to humans Trends Biochem. Sci. 34 2009 85 96
63. S. Mitola, C. Ravelli, E. Moroni, V. Salvi, D. Leali, and K. Ballmer-Hofer Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2 Blood 116 2010 3677 3680
64. P. Chiodelli, S. Mitola, C. Ravelli, P. Oreste, M. Rusnati, and M. Presta Heparan sulfate proteoglycans mediate the angiogenic activity of the vascular endothelial growth factor receptor-2 agonist gremlin Arterioscler., Thromb., Vasc. Biol. 31 2011 e116 e127
65. X. Li, Y. Zhang, H. Kang, W. Liu, P. Liu, and J. Zhang Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling J. Biol. Chem. 280 2005 19883 19887
66. M. Semenov, K. Tamai, and X. He SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor J. Biol. Chem. 280 2005 26770 26775
67. P. Schuck Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling Biophys. J. 78 2000 1606 1619
68. H.L. Sive, R.M. Grainger, and R.M. Harland Early Development of Xenopus laevis: A Laboratory Manual 1st edit. 2000 Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY
69. P.D.a.F.,.J. Nieuwkoop, and J. Faber Normal Table of Xenopus laevis (Deaden): A Systematical and Chronological Survey of the Development from the Fertilized Egg till the End of Metamorphosis 1994 Garland Publishing New York, NY